James J. Kohler

1.5k total citations
37 papers, 1.2k citations indexed

About

James J. Kohler is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, James J. Kohler has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Molecular Biology. Recurrent topics in James J. Kohler's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV-related health complications and treatments (7 papers). James J. Kohler is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV-related health complications and treatments (7 papers). James J. Kohler collaborates with scholars based in United States, Israel and Brazil. James J. Kohler's co-authors include William Lewis, Rodney Russ, Seyed Hamzeh Hosseini, Robert Santoianni, Elgin Green, Tomika Ludaway, John W. Sleasman, Maureen M. Goodenow, Thomas A. Brown and Latha Pathangey and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

James J. Kohler

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James J. Kohler United States	20	559	355	283	265	262	37	1.2k
Raquel Martínez Switzerland	23	703 1.3×	668 1.9×	412 1.5×	153 0.6×	249 1.0×	40	1.5k
J. Durant France	21	1.3k 2.3×	1.1k 3.2×	217 0.8×	250 0.9×	380 1.5×	91	1.9k
Pia Hartmann Germany	26	562 1.0×	239 0.7×	325 1.1×	53 0.2×	651 2.5×	76	1.9k
E Balestra Italy	20	476 0.9×	536 1.5×	277 1.0×	67 0.3×	270 1.0×	47	1.1k
Jiming Yin China	17	381 0.7×	136 0.4×	244 0.9×	45 0.2×	313 1.2×	42	1.2k
Donato Torre Italy	17	262 0.5×	188 0.5×	123 0.4×	94 0.4×	270 1.0×	44	886
Barbara Savarese United States	8	186 0.3×	120 0.3×	153 0.5×	50 0.2×	453 1.7×	10	900
N Vetter Austria	18	624 1.1×	514 1.4×	250 0.9×	190 0.7×	435 1.7×	42	1.4k
Véronique Joly France	20	699 1.3×	390 1.1×	143 0.5×	50 0.2×	251 1.0×	63	1.0k
Mauro Andreotti Italy	23	934 1.7×	874 2.5×	238 0.8×	242 0.9×	442 1.7×	99	1.8k

Countries citing papers authored by James J. Kohler

Since Specialization

Citations

This map shows the geographic impact of James J. Kohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Kohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Kohler more than expected).

Fields of papers citing papers by James J. Kohler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Kohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Kohler. The network helps show where James J. Kohler may publish in the future.

Co-authorship network of co-authors of James J. Kohler

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Kohler. A scholar is included among the top collaborators of James J. Kohler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Kohler. James J. Kohler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurwitz, Selwyn J., Keivan Zandi, Tamara R. McBrayer, et al.. (2024). Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. Viruses. 16(4). 651–651. 3 indexed citations

Zandi, Keivan, Vivian Vasconcelos Costa, Franck Amblard, et al.. (2022). Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice. Microorganisms. 10(11). 2098–2098. 3 indexed citations

Hurwitz, Selwyn J., Sijia Tao, Christina Gavegnano, et al.. (2021). Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study. The Journal of Clinical Pharmacology. 61(12). 1555–1566. 3 indexed citations

Tao, Sijia, Keivan Zandi, Leda Bassit, et al.. (2021). Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside. SHILAP Revista de lepidopterología. 2. 100045–100045. 19 indexed citations

Gavegnano, Christina, Woldeab B. Haile, Selwyn J. Hurwitz, et al.. (2020). Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model. Journal of NeuroVirology. 26(6). 838–845. 2 indexed citations

Zandi, Keivan, Leda Bassit, Franck Amblard, et al.. (2019). Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses. Antimicrobial Agents and Chemotherapy. 63(7). 28 indexed citations

Kalichman, Seth C., Chauncey Cherry, Moira O. Kalichman, et al.. (2018). Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP). JAIDS Journal of Acquired Immune Deficiency Syndromes. 78(1). 34–42. 22 indexed citations

Stoyanov, Evgeniy, Lina Mizrahi, Devorah Olam, et al.. (2015). Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis. Oncotarget. 6(13). 11047–11060. 22 indexed citations

Nettles, James H., Richard A. Stanton, Franck Amblard, et al.. (2014). Asymmetric Binding to NS5A by Daclatasvir (BMS-790052) and Analogs Suggests Two Novel Modes of HCV Inhibition. Journal of Medicinal Chemistry. 57(23). 10031–10043. 35 indexed citations

10.

North, Thomas W., Selwyn J. Hurwitz, Jesse D. Deere, et al.. (2014). Enhanced Antiretroviral Therapy in Rhesus Macaques Improves RT-SHIV Viral Decay Kinetics. Antimicrobial Agents and Chemotherapy. 58(7). 3927–3933. 9 indexed citations

11.

Kohler, James J., Seyed Hamzeh Hosseini, Elgin Green, et al.. (2010). Absence of Mitochondrial Toxicity in Hearts of Transgenic Mice Treated with Abacavir. Cardiovascular Toxicology. 10(2). 146–151. 3 indexed citations

12.

Koczor, Christopher A., James J. Kohler, & William Lewis. (2010). Transgenic mouse models of mitochondrial toxicity associated with HIV/AIDS and antiretrovirals. Methods. 51(4). 399–404. 7 indexed citations

13.

Kohler, James J., Seyed Hamzeh Hosseini, Elgin Green, et al.. (2009). Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Laboratory Investigation. 89(5). 513–519. 155 indexed citations

14.

Brown, Joseph N., et al.. (2008). HIV-1 Activates Macrophages Independent of Toll-Like Receptors. PLoS ONE. 3(12). e3664–e3664. 78 indexed citations

15.

Kohler, James J., Seyed H. Hosseini, Ioan C. Cucoranu, et al.. (2008). Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation. Laboratory Investigation. 89(2). 122–130. 15 indexed citations

16.

Hosseini, Seyed H., James J. Kohler, Chad P. Haase, et al.. (2007). Targeted Transgenic Overexpression of Mitochondrial Thymidine Kinase (TK2) Alters Mitochondrial DNA (mtDNA) and Mitochondrial Polypeptide Abundance. American Journal Of Pathology. 170(3). 865–874. 24 indexed citations

17.

Lewis, William, Brian J. Day, James J. Kohler, et al.. (2007). Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γ. Laboratory Investigation. 87(4). 326–335. 99 indexed citations

18.

Lewis, William, James J. Kohler, Seyed Hamzeh Hosseini, et al.. (2006). Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesis. AIDS. 20(5). 675–684. 86 indexed citations

19.

Kohler, James J., et al.. (2000). Effect of Preexisting Immunity to Salmonella on the Immune Response to Recombinant Salmonella enterica Serovar Typhimurium Expressing a Porphyromonas gingivalis Hemagglutinin. Infection and Immunity. 68(6). 3116–3120. 28 indexed citations

20.

Kohler, James J., Latha Pathangey, & Thomas A. Brown. (1998). Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiology and Immunology. 13(2). 81–88. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact